GO:0015195 L-threonine transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015195 defines the molecular function that enables transfer of L-threonine across a membrane, a process essential for amino acid homeostasis and cellular metabolism.
• L-threonine transporters are members of the amino acid-polyamine-organocation (APC) superfamily and the neurotransmitter:sodium symporter (NSS) family, and they often co-transport sodium or protons.
• Dysregulation of threonine transport is linked to metabolic disorders, cancer, and inflammatory diseases through altered mTORC1 signaling and autophagy.
• Key genes include SLC1A4, SLC1A5, SLC7A5, SLC38A1, SLC38A2, SLC38A9, and SLC6A14, which mediate threonine uptake or exchange in various tissues.
• Studying this activity requires methods such as radiolabeled uptake assays, electrophysiology, and CRISPR-based knockout models to dissect transporter function.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to accelerate research on L-threonine transporters.
Description
L-threonine transmembrane transporter activity (GO:0015195) is a molecular function that enables the transfer of L-threonine from one side of a membrane to the other. L-threonine is an essential amino acid that serves as a precursor for protein synthesis, glycine, and acetyl-CoA, and its transport across cellular membranes is critical for metabolic regulation. This activity is mediated by integral membrane proteins that undergo conformational changes to shuttle threonine, often coupled to sodium or proton gradients. Researchers study this term to understand how cells acquire threonine, how transporters contribute to mTORC1 signaling and autophagy, and how their dysfunction leads to disease. The importance of L-threonine transport extends to immunology, cancer biology, and gut health, where amino acid availability influences immune cell function and epithelial barrier integrity.
L-threonine transmembrane transporter activity At A Glance
| GO ID | GO:0015195 |
|---|---|
| GO term | L-threonine transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | L-threonine permease activity; L-threonine transporter activity; threonine/serine:sodium symporter activity |
| Definition | Enables the transfer of L-threonine from one side of a membrane to the other. |
| Major function | Mediates the movement of L-threonine across biological membranes, often coupled to sodium or proton gradients. |
| Related transporters | SLC1A4, SLC1A5, SLC7A5, SLC38A1, SLC38A2, SLC38A9, SLC6A14 |
| Cellular location | Plasma membrane, lysosomal membrane, mitochondrial membrane |
| Biological context | Amino acid homeostasis, mTORC1 signaling, autophagy, immune response |
What Is GO:0015195?
The Gene Ontology term GO:0015195 describes a molecular function: the directed movement of L-threonine across a membrane. L-threonine is (2R*,3S*)-2-amino-3-hydroxybutanoic acid. This activity is typically performed by transmembrane transporter proteins that facilitate the passage of threonine, either passively or through secondary active transport coupled to ion gradients. The term encompasses synonyms such as L-threonine permease activity, L-threonine transporter activity, and threonine/serine:sodium symporter activity, reflecting the functional diversity of proteins that carry out this process.
Why Is L-threonine transmembrane transporter activity Important in Cell Biology?
L-threonine transmembrane transporter activity is fundamental for cellular metabolism because threonine is an essential amino acid that cannot be synthesized by humans and must be obtained from the diet. Transporters regulate intracellular threonine levels, which in turn affect protein synthesis, one-carbon metabolism, and signaling through mTORC1. Dysregulated threonine transport has been implicated in cancer, where tumor cells upregulate amino acid transporters to support rapid growth, and in inflammatory diseases where altered amino acid availability impacts immune cell function and gut barrier integrity. Understanding this activity at the molecular level is therefore crucial for developing therapeutic strategies targeting metabolic vulnerabilities.
• Threonine is an essential amino acid; its transport is required for protein synthesis and cell growth.
• Transporters for threonine often co-transport sodium, linking amino acid uptake to ion gradients and cellular energetics.
• Intracellular threonine levels influence mTORC1 signaling, a master regulator of cell growth and autophagy.
• Dysregulated threonine transport contributes to cancer metabolic reprogramming and tumor progression.
• In inflammatory bowel disease, altered amino acid transport affects gut epithelial barrier and immune responses.
• Threonine transport is critical for immune cell activation and differentiation, impacting autoimmune diseases.
• Genetic variants in threonine transporters are associated with neurological disorders and metabolic diseases.
• Studying threonine transport provides insights into autophagy regulation and lysosomal amino acid sensing.
• CRISPR screens targeting transporters can identify novel therapeutic targets in metabolic diseases.
• Pharmacological modulation of threonine transporters holds promise for treating cancer and inflammatory conditions.
What Happens During L-threonine transmembrane transporter activity?
Substrate Recognition and Binding
In simple terms: The transporter first grabs the threonine molecule from one side of the membrane.
Transporters specific for L-threonine possess a binding pocket that recognizes the amino acid with high affinity. This pocket is formed by transmembrane helices and often includes residues that interact with the amino and carboxyl groups of threonine. For example, members of the SLC1 family, such as SLC1A4 and SLC1A5, bind threonine and other small neutral amino acids in a sodium-dependent manner. The binding step is reversible and determines the specificity of the transporter.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move threonine across the membrane.
Upon substrate binding, the transporter undergoes a conformational change that exposes the binding site to the opposite side of the membrane. This alternating access mechanism is driven by thermal energy and, in secondary active transporters, by the electrochemical gradient of co-transported ions such as sodium or protons. The translocation step is rate-limiting and can be regulated by post-translational modifications or interacting proteins.
Ion Coupling and Energetics
In simple terms: Many threonine transporters use sodium or protons to power the transport.
Threonine transport is often coupled to the movement of sodium ions down their concentration gradient, as seen in the threonine/serine:sodium symporter activity synonym. This coupling allows threonine to be accumulated against its own concentration gradient. The stoichiometry of ion coupling varies among transporters and influences their transport efficiency and regulation. In lysosomes, SLC38A9 functions as an arginine sensor and also transports threonine, linking amino acid availability to mTORC1 signaling.
Release and Reset
In simple terms: After delivering threonine, the transporter returns to its original shape to start again.
Once threonine is released on the trans side of the membrane, the transporter reverts to its initial conformation, ready for another cycle. This reset may be facilitated by the dissociation of co-transported ions. The entire cycle occurs within milliseconds to seconds, allowing rapid adjustments to cellular amino acid levels. Dysfunction in any step can lead to impaired threonine uptake and metabolic consequences.
Key Genes Involved in GO:0015195 L-threonine transmembrane transporter activity
The following genes encode proteins that exhibit L-threonine transmembrane transporter activity or are directly involved in its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A4 | Sodium-dependent transporter for threonine, serine, and alanine | Mutations linked to neurological disorders; studied in amino acid transport |
| SLC1A5 | Neutral amino acid transporter for threonine, glutamine, and others | Upregulated in cancer; target for metabolic therapy |
| SLC7A5 | L-type amino acid transporter subunit that exchanges threonine | Involved in mTORC1 activation and cancer growth |
| SLC38A1 | Sodium-coupled neutral amino acid transporter for threonine | Regulates amino acid homeostasis in liver and brain |
| SLC38A2 | Sodium-coupled neutral amino acid transporter for threonine | Implicated in cell growth and autophagy |
| SLC38A9 | Lysosomal arginine sensor and threonine transporter | Activates mTORC1 in response to amino acids |
| SLC6A14 | Sodium- and chloride-dependent transporter for threonine | Overexpressed in cancer; potential drug target |
| SLC3A2 | Heavy subunit of amino acid transporters, including threonine | Required for transport activity of SLC7A5 |
| SLC43A1 | Sodium-independent transporter for threonine | Expressed in liver and pancreas; role in metabolism |
| SLC43A2 | Sodium-independent transporter for threonine | Involved in T-cell function and cancer immunity |
| SLC16A10 | Aromatic amino acid transporter that also transports threonine | Expressed in kidney and intestine |
| SLC36A1 | Proton-coupled amino acid transporter for threonine | Lysosomal and plasma membrane transport |
| SLC15A4 | Peptide/histidine transporter with threonine transport activity | Implicated in autoimmune diseases |
| SLC7A11 | Cystine/glutamate exchanger with threonine transport | Regulates oxidative stress and ferroptosis |
| SLC1A1 | Glutamate transporter that also transports threonine | Neuronal function and excitotoxicity |
| SLC6A19 | Neutral amino acid transporter for threonine | Mutations cause Hartnup disorder |
| SLC25A15 | Mitochondrial ornithine transporter with threonine transport | Urea cycle and hyperammonemia |
| SLC25A22 | Mitochondrial glutamate transporter with threonine transport | Epileptic encephalopathy |
How Is L-threonine transmembrane transporter activity Regulated?
L-threonine transmembrane transporter activity is regulated at multiple levels. Transcriptional regulation controls transporter expression in response to amino acid availability, with transcription factors such as ATF4 inducing stress-responsive transporters. Post-translational modifications, including phosphorylation and ubiquitination, modulate transporter trafficking and stability. The mTORC1 pathway senses intracellular amino acids, including threonine, through lysosomal transporters like SLC38A9, creating a feedback loop that adjusts transport activity to metabolic needs. Autophagy also influences amino acid pools by degrading proteins, thereby affecting substrate availability for transporters. In inflammatory conditions, cytokines can alter transporter expression, linking immune signaling to amino acid transport.
L-threonine transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC1A4 | Neurodevelopmental disorder with microcephaly | Knockout mouse, patient-derived iPSCs |
| SLC1A5 | Cancer proliferation and mTORC1 activation | Xenograft models, CRISPR knockout cell lines |
| SLC7A5 | Tumor growth and immune evasion | Conditional knockout mice, organoids |
| SLC38A9 | mTORC1 signaling and lysosomal amino acid sensing | Knock-in reporter cells, knockout mice |
| SLC6A14 | Cancer and obesity | Overexpression cell lines, patient samples |
Cancer Metabolism
Many cancer cells upregulate amino acid transporters to meet increased demand for threonine and other nutrients. For example, SLC1A5 and SLC7A5 are overexpressed in various tumors and support mTORC1 activation and proliferation. Targeting these transporters can inhibit tumor growth and sensitize cells to chemotherapy. Threonine transport also contributes to one-carbon metabolism, which is essential for nucleotide synthesis in cancer.
Inflammatory Bowel Disease
Altered amino acid transport in the gut epithelium affects barrier function and immune responses. Threonine is a key component of mucin glycoproteins, and its uptake influences mucin production and epithelial repair. Dysregulated transport may exacerbate inflammation in inflammatory bowel disease (IBD) by impairing barrier integrity and promoting microbial dysbiosis.
Neurological Disorders
Threonine transporters in the brain regulate neurotransmitter precursor availability and neuronal excitability. Mutations in SLC1A4 cause a neurodevelopmental disorder with microcephaly and seizures. SLC1A1 dysfunction has been linked to obsessive-compulsive disorder and schizophrenia, highlighting the importance of threonine transport in synaptic function.
Autoimmune Diseases
Amino acid transporters modulate immune cell activation and differentiation. SLC43A2-mediated threonine transport in T cells influences their effector functions, and its inhibition can enhance antitumor immunity. In autoimmune conditions, altered transport may contribute to aberrant T-cell responses and tissue damage.
From L-threonine transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC1A5 impair threonine uptake and tumor growth? | CRISPR knockout in cancer cell lines followed by radiolabeled uptake and xenograft assays |
| How does a point mutation in SLC38A9 affect mTORC1 signaling? | CRISPR point mutation knock-in in HEK293T cells with mTORC1 reporter assays |
| Can overexpression of SLC7A5 enhance threonine transport? | Doxycycline-inducible overexpression in HeLa cells with transport assays |
| What is the tissue-specific role of SLC1A4 in brain development? | Conditional knockout mouse models with behavioral and metabolic phenotyping |
| Does tagging SLC38A9 with GFP alter its lysosomal localization? | CRISPR knock-in of GFP tag in HeLa cells followed by live-cell imaging |
| Which transporters are essential for threonine uptake in T cells? | CRISPR library screening in primary T cells with threonine deprivation |
How to Study the L-threonine transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Characterization of transporter specificity and inhibitors |
| Electrophysiology | Ion currents coupled to transport | Mechanistic studies of electrogenic transporters |
| CRISPR knockout screen | Genes required for threonine uptake | Discovery of novel transporters and regulators |
| Proteomics | Transporter protein abundance | Expression profiling in disease models |
| Metabolomics | Intracellular threonine levels | Metabolic flux analysis |
| Live-cell imaging | Transporter localization and trafficking | Dynamic regulation studies |
| Surface biotinylation | Plasma membrane expression | Trafficking and internalization assays |
Radiolabeled Transport Assays
Radiolabeled L-threonine uptake assays are the gold standard for measuring transporter activity. Cells expressing candidate transporters are incubated with 3H- or 14C-labeled threonine, and uptake is quantified by scintillation counting. This method allows determination of kinetic parameters such as Km and Vmax, and can be used to test inhibitors.
Electrophysiology
For electrogenic transporters that couple threonine transport to ion fluxes, electrophysiological techniques such as two-electrode voltage clamp in Xenopus oocytes can measure transport currents. This provides real-time information on stoichiometry, voltage dependence, and substrate specificity.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify genes required for threonine uptake or sensitivity to threonine deprivation. Cells are transduced with a lentiviral sgRNA library, selected under low threonine conditions, and sgRNA abundance is analyzed by next-generation sequencing. This approach has uncovered novel transporters and regulators.
Proteomics and Metabolomics
Mass spectrometry-based proteomics can quantify transporter protein levels, while metabolomics measures intracellular threonine and related metabolites. Combining these methods reveals how transport activity affects metabolic networks and signaling pathways.
How CRISPR Can Be Used to Study GO:0015195 L-threonine transmembrane transporter activity
Knockout
CRISPR knockout of genes encoding threonine transporters, such as SLC1A5 or SLC7A5, allows researchers to assess their contribution to threonine uptake and downstream phenotypes. Knockout cell lines can be generated by introducing indels in early exons, followed by validation of protein loss and functional assays.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect residues critical for substrate binding or ion coupling. For example, mutating a conserved serine in the binding pocket of SLC1A4 can abolish threonine transport, providing insights into mechanism.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or reporter genes enables visualization and purification of transporters. This is useful for studying localization, trafficking, and interacting partners. Knock-in of disease mutations in model organisms can recapitulate human phenotypes.
Overexpression
Overexpression of a threonine transporter using CRISPR activation or lentiviral delivery can enhance transport activity, useful for gain-of-function studies and for producing sufficient protein for structural analysis. Overexpression models help identify rate-limiting steps and potential toxicities.
How EDITGENE Supports L-threonine transmembrane transporter activity Research
Researchers studying L-threonine transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in threonine uptake, metabolic signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of these transporters.
Contact EDITGENE today to design your custom CRISPR model for L-threonine transmembrane transporter activity research.
Frequently Asked Questions About L-threonine transmembrane transporter activity
What is L-threonine transmembrane transporter activity?
It is a molecular function (GO:0015195) that enables the transfer of L-threonine across a membrane, often coupled to sodium or proton gradients.
What genes are involved in L-threonine transmembrane transporter activity?
Key genes include SLC1A4, SLC1A5, SLC7A5, SLC38A1, SLC38A2, SLC38A9, and SLC6A14, among others.
How is L-threonine transport regulated?
It is regulated by amino acid availability, mTORC1 signaling, transcriptional programs, and post-translational modifications.
What diseases are associated with defective threonine transport?
Dysregulation is linked to cancer, inflammatory bowel disease, neurological disorders, and autoimmune diseases.
What methods are used to study threonine transporters?
Common methods include radiolabeled uptake assays, electrophysiology, CRISPR screens, proteomics, and metabolomics.
Can CRISPR be used to study threonine transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful approaches to dissect transporter function.
What is the role of SLC38A9 in threonine transport?
SLC38A9 is a lysosomal transporter that senses arginine and also transports threonine, linking amino acid availability to mTORC1 activation.
How does threonine transport affect cancer?
Cancer cells upregulate threonine transporters to support growth and survival, making them potential therapeutic targets.
What is the connection between threonine transport and autophagy?
Threonine availability influences mTORC1 signaling, which in turn regulates autophagy; transporters thus indirectly control autophagic flux.
Where can I find validated CRISPR models for threonine transporters?
EDITGENE offers custom CRISPR services including knockout, knock-in, and overexpression for any threonine transporter gene.
Conclusion
L-threonine transmembrane transporter activity (GO:0015195) is a critical molecular function that governs cellular threonine uptake and influences diverse physiological and pathological processes. From cancer metabolism to immune regulation and neurological function, these transporters are emerging as important therapeutic targets. Continued research using advanced CRISPR models and functional assays will further elucidate their mechanisms and disease relevance.
References
- 1. Byrnes K et al.. 2022. Therapeutic regulation of autophagy in hepatic metabolism.. Acta Pharm Sin B 12(1):33-49 PMID: 35127371
- 2. Xu Y et al.. 2020. Emerging views of mitophagy in immunity and autoimmune diseases.. Autophagy 16(1):3-17 PMID: 30951392
- 3. Larabi A et al.. 2020. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.. Autophagy 16(1):38-51 PMID: 31286804
- 5. Foerster EG et al.. 2022. How autophagy controls the intestinal epithelial barrier.. Autophagy 18(1):86-103 PMID: 33906557
- 8. Castellano BM et al.. 2017. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.. Science 355(6331):1306-1311 PMID: 28336668
